CRISPR trial restores sight in 9 of 10 patients with inherited blindness A Phase 3 CRISPR trial reports vision improvement in 9 of 10 patients with inherited retinal disease, raising hopes for new treatments for genetic blindness. /news/crispr-trial-restores-sight-in-9-of-10-patients